Alfa Aesar acquires Biomedical Technologies

Heysham, UK – Research chemical manufacturer Alfa Aesar says it has completed the purchase of Biomedical Technologies (BTI) of Stoughton, MA.

BTI has been manufacturing life science research products for more than 30 years. Its product line includes specialty proteins, cell culture additives and highly specific immunoassay tools.

“The acquisition of BTI brings protein research and characterization, all types of profiling tools, and certain separation technologies and provides opportunities for Alfa Aesar to leverage BTI’s manufacturing capabilities to enhance its overall product offering,” says Julie Butterfield, Alfa Aesar’s general manager.